Abrupt development of Dupuytren's contractures with the BRAF inhibitor vemurafenib

被引：2
|
作者：
Couderc, Marion [1 ]
Soubrier, Martin [1 ]
机构：
[1] Clermont Ferrand Teaching Hosp, Dept Rheumatol, F-63000 Clermont Ferrand, France
来源：
JOINT BONE SPINE | 2014年 / 81卷 / 04期
关键词：
Vemurafenib; Dupuytren; BRAF inhibitor; DISEASE; MELANOMA;
D O I：
10.1016/j.jbspin.2013.12.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：373 / 374
页数：2
相关论文
共 50 条
  • [1] Dupuytren's contractures associated with the BRAF inhibitor vemurafenib: A case report
    Chan S.W.
    Vorobiof D.A.
    Journal of Medical Case Reports, 9 (1)
  • [2] Dupuytren's contractures secondary to BRAF kinase inhibitor therapy
    Bicknell, Lindsay Taylor Morgan
    Ciurea, Ana
    Diaz, Lucia
    Hymes, Sharon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB179 - AB179
  • [3] Dynamism in Dupuytren's contractures
    Rodrigues, J. N.
    Zhang, W.
    Scammell, B. E.
    Davis, T. R. C.
    JOURNAL OF HAND SURGERY-EUROPEAN VOLUME, 2015, 40 (02) : 166 - 170
  • [4] Bilateral Dupuytren's contractures of the thumb interphalangeal joints
    Miranda, B. H.
    Elliott, C.
    Fahmy, F. S.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2012, 65 (12): : 1738 - 1740
  • [5] Treating Metastatic Melanoma With the BRAF Inhibitor Vemurafenib and Mechanisms of Resistance
    Chapman, P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S24 - S24
  • [6] Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
    Simon J. B. Aylwin
    Istvan Bodi
    Ronald Beaney
    Pituitary, 2016, 19 : 544 - 546
  • [7] Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor
    Aylwin, Simon J. B.
    Bodi, Istvan
    Beaney, Ronald
    PITUITARY, 2016, 19 (05) : 544 - 546
  • [8] Acute Renal Failure Associated With the New BRAF Inhibitor Vemurafenib
    Launay-Vacher, Vincent
    Zimner-Rapuch, Sarah
    Poulalhon, Nicolas
    Fraisse, Thibault
    Garrigue, Valerie
    Gosselin, Morgane
    Amet, Sabine
    Janus, Nicolas
    Deray, Gilbert
    CANCER, 2014, 120 (14) : 2158 - 2163
  • [9] Case of severe acneiform eruptions associated with the BRAF inhibitor vemurafenib
    Ansai, Osamu
    Fujikawa, Hiroki
    Shimomura, Yutaka
    Abe, Riichiro
    JOURNAL OF DERMATOLOGY, 2017, 44 (03): : E15 - E16
  • [10] The Development of Vemurafenib for BRAF-mutated, Metastatic Melanoma
    Borellini, F.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S74 - S74
12345